Insulin resistance, a major feature of both the metabolic syndrome and type 2 diabetes has been associated with increased mortality for women with breast cancer, possibly related to the growth-promoting effects of insulin, insulin-like growth factors (IGF), and to hyperglycemia (9, 10). The gene discussed is INS; the disease is type 2 diabetes mellitus.